Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps
a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly …

Allergen immunotherapy is effective in patients with allergic rhinitis (AR) and, unlike
antiallergic drugs, has been shown to modify the underlying cause of the disease, with …

To cite this article: Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of
sublingual immunotherapy (SLIT). Allergy 2011; 66: 740–752. Abstract Allergic rhinitis is …

Appeared at the beginning of the 20th century, allergen-specific immunotherapy (SIT) has
long been used in allergic rhinitis and asthma without any knowledge of its mechanisms of …

Allergic rhinitis is a common condition which, at its most severe, can significantly impair
quality of life despite optimal treatment with antihistamines and topical nasal corticosteroids …

Background Allergic rhinitis is a common condition which, at its most severe, can
significantly impair quality of life despite optimal treatment with antihistamines and topical …

OBJECTIVE: To obtain a current understanding of the mechanisms, clinical indications,
efficacy, and safety of sublingual immunotherapy (SLIT) for the treatment of children and …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

Background Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa impacting
up to 25% of Canadians. The standard of care for AR includes a treatment plan that takes …

OBJECTIVE: To review the available published data concerning the use of sublingual
immunotherapy (SLIT) in respiratory allergy to primarily evaluate the clinical efficacy and …